Adefovir dipivoxil modulates cytokine expression in Th1/Th2 cells in patients with chronic hepatitis B

Molecular Medicine Reports

Volumn 5, Issue 1, 2012, Pages 184-189

  Piao, Rong Li ^a   Liu, Yuan Yuan ^a   Tian, Dan ^a   Ma, Zhen Hua ^a   Zhang, Manli ^a   Zhao, Chong ^a   Niu, Jun Qi ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Adefovir dipivoxil; Chronic hepatitis B; Flow cytometry; IL 10; IL 4; IL 6; Interferon ; Interleukin (IL) 2; Tumor necrosis factor

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOMODULATION; LIVER FUNCTION; MALE; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; TREATMENT RESPONSE;

ADENINE; ADMINISTRATION, ORAL; ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; CYTOKINES; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; TH1 CELLS; TH2 CELLS; TIME FACTORS;

HEPATITIS B VIRUS;

EID: 84855244100     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.627     Document Type: Article

References (25)

1. Marcellin P, Chang TT, Lim SG, et al.: Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 348: 808-816, 2003. (Pubitemid 36245757)
2. Liang X, Bi S, Yang W, et al.: Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 27: 6550-6557, 2009.
3. Van der Molen RG, Sprengers D, Biesta PJ, Kusters JG and Janssen HL: Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV. Hepatology 44: 907-914, 2006. (Pubitemid 46489555)
4. Schiff E, Neuhaus P, Tillmann H, Samuel D, Terrault N and Marcellin P: Safety and efficacy of adefovir dipivoxil for the treatment of lamivudine resistant HBV in patients post liver transplantation. Hepatology 34: 446A, 2001.
5. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al.: Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med 348: 800-807, 2003. (Pubitemid 36245756)
6. Peters MG, Hann Hw H, Martin P, et al.: Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology 126: 91-101, 2004. (Pubitemid 38040727)
7. Delaugerre C, Marcelin AG, Thibault V, et al.: Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine. Antimicrob Agents Chemother 46: 1586-1588, 2002. (Pubitemid 34415353)
8. Lee M, Lee SK, Son M, Cho SW, Park S and Kim HI: Expression of Th1 and Th2 type cytokines responding to HBsAg and HBxAg in chronic hepatitis B patients. J Korean Med Sci 14: 175-181, 1999.
9. Grewe M, Bruijnzeel-Koomen CA, Schopf E, et al.: A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19: 359-361, 1998. (Pubitemid 28392277)
10. Lechmann M, Woitas RP, Langhans B, et al.: Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C. J Hepatol 31: 971-978, 1999.
11. Li QQ and Bever CT: Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription. Neurochem Res 26: 125-133, 2001. (Pubitemid 32661451)
12. Mosmann TR and Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173, 1989. (Pubitemid 19138011)
13. Yu Y, Wu H, Tang Z and Zang G: CTLA4 silencing with siRNA promotes deviation of Th1/Th2 in chronic hepatitis B patients. Cell Mol Immunol 6: 123-127, 2009.
14. Viallard JF, Pellegrin JL, Ranchin V, et al.: Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 115: 189-195, 1999. (Pubitemid 29030384)
15. Nagai H, Miyaki D, Matsui T, et al.: Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy. Cancer Chemother Pharmacol 62: 959-963, 2008.
16. Naugler WE, Sakurai T, Kim S, et al.: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317: 121-124, 2007. (Pubitemid 47056470)
17. Bertoletti A, D'Elios MM, Boni C, et al.: Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 112: 193-199, 1997. (Pubitemid 27009002)
18. Lorentz K: Approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes part 9. IFCC method for α-amylase (1, 4-α-D-Glucan 4-Glucanohydrolase, EC 3.2.1.1). International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Committee on Enzymes. Clin Chem Lab Med 36: 185-203, 1998.
19. Bergmeyer H, Hørder M and Rej R: International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: Approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase (L-alanine: 2-oxoglutarate aminotransferase, EC 2.6.1.2). J Clin Chem Clin Biochem 24: 481-495, 1986. (Pubitemid 16058696)
20. Pauwels R, Balzarini J, Schols D, et al.: Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents. Antimicrob Agents Chemother 32: 1025-1030, 1988.
21. Angus P, Vaughan R, Xiong S, et al.: Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 125: 292-297, 2003. (Pubitemid 36929407)
22. North M, Ivory K, Funauchi M, Webster A, Lane A and Farrant J: Intracellular cytokine production by human CD4 and CD8 T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry. Clin Exp Immunol 105: 22, 1996.
23. Milich D: Influence of T-helper cell subsets and cross-regulation in hepatitis B virus infection. J Viral Hepat 4: 48-59, 1997.
24. Marinos G, Rossol S, Carucci P, et al.: Immunopathogenesis of hepatitis B virus recurrence after liver transplantation. Transplantation 69: 559, 2000.
25. Xing TJ, Zhang L, Luo KX, et al.: Intrahepatic expression of Th1/Th2 cytokine in HBV infection and its clinical significance. Med J Chin People's Liberation Army 25: 235-237, 2000.